Pricing

Atalanta Therapeutics

1 follower

‌

Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing the proprietary RNA interference platform.

Industries

Biotechnology, Education

Headquarters

Boston, United States

Employees

11-50

Links

Org chart

Alicia Secor

President & CEO

Alicia Secor

Collapse

Aimee L. Jackson

Chief Scientific Officer

Morgan Molloy

Chief Corporate Development Officer

Bart G. Newland

General Counsel

Maurice Smith

Senior Director & Controller

Michele Keough

SVP, Program & Alliance Management

Stephen Burke

SVP, Human Resources

Guillermo Yudowski

VP, Biochemistry & Pharmacology, In vitro Biology

Brittany Ferdman

Purchasing Coordinator

Anastasia Khvorova

Co-founder

Craig Mello

Co-founder

Jeff Young

Chief Financial Officer

Serena Hung

Chief Medical Officer

Mark Murphy

Senior Facilities Manager

Matthew Grear

Lab Operations Manager

Antonio N.

Sr. Director Information Technology

Teams

+10

Scientific Research Team

13 members

Scientific and Technical Advisory

10 members

Leadership Team

7 members

Operations Team

4 members

Research and Development

5 members

Similar companies

Immunome

2 followers

Thermo Fisher Scientific

155 followers

McGraw-Hill

24 followers

BeiGene

19 followers

Cytiva

10 followers

Houston ISD

7 followers

University of Richmond

7 followers

Merck

211 followers

Tessera Therapeutics

2 followers

Vial

5 followers

MITCHELL HAMLINE SCHOOL OF LAW

1 follower

Explore companies